Indian Pharmacopoeia (IP) is published by the Indian Pharmacopoeia Commission (IPC) on behalf of the Ministry of Health and Family Welfare, Government of India in accordance with the requirements of the Medicines and Cosmetics Act, 1940 and the Rules, 1945. Intellectual property is recognized as the official book of standards for medicines manufactured and/or marketed in India. Intellectual property contains a set of authoritative analytical methods and specifications of medicines for their identity, purity and concentration. IP standards are authoritative in nature and are enforced by regulatory bodies to ensure the quality of medicines in India. In terms of quality assurance and at the time of litigation before the courts, intellectual property standards are legally permitted. The standards prescribed in the IP are intended to demonstrate compliance with the regulatory requirements of an article. The criteria to be met are as follows: The interpretation of a monograph must comply with all general requirements, test methods, texts and notices concerning it in intellectual property. A product is of standard quality only if it meets all the requirements of the monograph. The Research and Analytical Development (AR&D) department reinforces IPC`s mission and vision by achieving the highest pharmaceutical standards through its dynamic research activities. The AR&D department continuously publishes changes to analytical testing procedures in accordance with the latest technological requirements. The Research and Development Division is also responsible for the validation and verification of IP monographs. The department also targets R&D activities to modernize monographs.

✔ Global Regulatory Updates ✔ Pharmaceutical News Interview ✔ Questions and Answers ✔ All guidelines in one place Analytical support for skills development and drug discovery Editable pharmaceutical documents in MS Word format. SOPs, protocols, blueprints, ready-to-use manuals and more. The Indian Pharmacopoeia Commission (IPC) is an autonomous body of India`s Ministry of Health and Family Welfare. IPC was established to set standards for drugs in the country. Its basic function is to regularly update the standards of drugs commonly needed to treat diseases in this region. It publishes official documents to improve the quality of medicines by adding new monographs and updating existing monographs in the form of the Indian Pharmacopoeia (PI). In addition, it promotes the rational use of generics through the publication of the National Formulary of India. Intellectual property prescribes standards for the identity, purity and concentration of pharmaceutical products, which are primarily required from the perspective of human and animal health care. IPC also offers IP Reference Substances (IPRS), which serve as fingerprints for the identification of an article to be tested and its purity required by IP. Applications are invited to fill the four posts of Registrar of the Upper Division by delegation (including short-term contracts). Reference substances. Some monographs require the use of a reference chemical or biological reference preparation or reference spectrum These are authentic specimens that have been selected and tested for fitness for the use prescribed in the pharmacopoeia and may not be appropriate in other circumstances.

IP reference substances, abbreviated IPRS (and referred to as RS in individual monographs), are published by the Indian Pharmacopoeia Commission (IPC). These are the official standards for arbitration. Secondary standards (working standards) may be used for routine analysis, provided that they are standardized to the reference substances at regular intervals. Reference biological substances, also abbreviated IPRS, and standard preparations of antibiotics are supplied by bodies authorised by the IPC. They are standardized in relation to international standards and reference preparations established by the World Health Organization (WHO). The efficacy of these preparations is expressed in international units. The Indian Pharmacopoeia Commission (IPC) maintains the quality management system through its Quality Assurance (QA) Department. The quality assurance department plays an important role in maintaining quality standards. The objective of the Quality Assurance Department is to maintain the quality system of the Indian Pharmacopoeia Laboratory of the Indian Pharmacopoeia Commission and its compliance with the “General competence requirement for testing and calibration laboratories” (ISO/IEC 17025:2017), “General competence requirement for manufacturer of reference materials” (ISO/IEC 17034:2016), “Conformity assessment – General proficiency testing requirements” (ISO/IEC 17043:2010) and the WHO Prequalification Ensure. Compliance with the system and procedures established by the IPC.

Please do not spam. Comments with links will not be published. CEO welcomes Indian Pharmacopoeia Commission as pilot project for global expansion India`s Pharmacovigilance Programme (PvPI) was established with the overall aim of protecting the health of 1.27 billion people in India.